Seeing as we have enough members around the table, we will call the meeting to order.
I want to thank the witnesses for coming forward. This is our last official day of witnesses before we bring in the department for one more look at it, so we're crowding very close to the end.
I'll just let the witnesses know that we want to leave a bit of time for the committee to be able to discuss the report in camera, right at the end of the meeting.
So with that, we will want to welcome our witnesses who are coming forward to present on this important issue. This is pursuant to Standing Order 108(2), the study on prescription drugs, the common drug review. I believe this is our eighth meeting.
Thank you for coming. We look forward to your presentation to the committee.
We have with us, from the University of British Columbia, Dr. Steve Morgan. Steve Morgan, it's good to have you with us. You're from the Centre for Health Services and Policy Research.
Also, from the University of Alberta, we have Dr. Devidas Menon. It's good to have you here from the School of Public Health.
And, as an individual, we have Jean-Claude St-Onge. It's good to have you here as well.
With that, we will open the floor in that order, with the University of British Columbia, starting with Dr. Morgan.
The floor is yours. You have 10 minutes. We look forward to your presentation.